Author: OurCrowd

[Axiom Space in WebProNews] Axiom Space, Red Hat launch orbital data center for AI on ISS

Sep 2, 2025 |

In a groundbreaking push to extend computing frontiers beyond Earth’s atmosphere, a prototype orbital data center has been launched to the International Space Station (ISS), orbiting approximately 400 kilometers above the planet. This initiative, spearheaded by Axiom Space in collaboration with Red Hat and sponsored by the ISS National Laboratory, aims to test the viability of edge computing in the harsh environment of space. Delivered via a SpaceX mission in August 2025, the compact system represents a pivotal step toward enabling real-time data processing for future space exploration, where latency from Earth-based servers could hinder critical operations. Read...

Read More

[Anthropic in Anthropic] Anthropic raises $13B Series F at $183B post-money valuation

Sep 2, 2025 |

Anthropic has completed a Series F fundraising of $13 billion led by ICONIQ. This financing values Anthropic at $183 billion post-money. Along with ICONIQ, the round was co-led by Fidelity Management & Research Company and Lightspeed Venture Partners. The investment reflects Anthropic’s continued momentum and reinforces our position as the leading intelligence platform for enterprises, developers, and power users. Read...

Read More

[Alpha Tau in Globe Newswire] Alpha Tau successfully treats first patient in its U.S. multi-center pancreatic cancer clinical trial

Sep 2, 2025 |

JERUSALEM, Sept. 02, 2025 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT® today announced that the first patient has been treated in its U.S. multi-center pancreatic cancer pilot study, known as IMPACT (Intratumoral Pancreatic Alpha Combination Trial), evaluating the safety, feasibility, and efficacy of Alpha DaRT in combination with chemotherapy for patients with newly diagnosed unresectable locally advanced or metastatic pancreatic adenocarcinoma. Read...

Read More

[CropX in PR Newswire] CropX acquires Acclym (formerly Agritask) to power enterprise-scale sustainable food systems

Sep 2, 2025 |

TEL-AVIV, Israel, Sept. 2, 2025 /PRNewswire/ — CropX Technologies, a global leader in digital agronomic solutions, announced today its acquisition of Acclym (formerly Agritask), an enterprise-grade agricultural intelligence company with a 15-year track record of enabling top food and beverage brands to deliver on their agricultural sustainability commitments. This marks the seventh strategic acquisition by CropX, following its 2024 acquisition of nitrogen sensor innovator EnGeniousAg and 2023 acquisition of Australia’s Green Brain. Read...

Read More

[Commonwealth Fusion Systems in ACN Newswire] Mitsubishi Corporation invests in Commonwealth Fusion Systems, a US fusion energy start-up from MIT 

Sep 2, 2025 |

Massachusetts, USA, September 2, 2025 – (JCN Newswire) – Mitsubishi Corporation (“MC”) is pleased to announce its participation in a third-party allotment of shares by Commonwealth Fusion Systems LLC (Headquarter: Massachusetts, USA, Representative: Bob Mumgaard, “CFS”), a fusion energy start-up originating from MIT *1. This investment was made in collaboration with a consortium of 12 Japanese companies *2 (“Japanese Consortium”). In the field of fusion energy, this investment builds on MC’s previous investment in Kyoto Fusioneering Ltd., announced on May 17, 2023. Read more...

Read More